Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 24-Jan-24 5:17 PM View:  | Dunoyer Marc Director | Orchard Therapeutics Plc (ORTX) | 24-Jan-24 | Disposition | 37,179 | -- | -- | (100%) 37.18K to 0 | |
| 24-Jan-24 5:25 PM View: | Rowland Charles A Jr Director | Orchard Therapeutics Plc (ORTX) | 24-Jan-24 | Disposition | 12,294 | -- | -- | (100%) 12.29K to 0 | |
| 24-Jan-24 5:18 PM View: | Gaspar Bobby Chief Executive Officer Director | Orchard Therapeutics Plc (ORTX) | 24-Jan-24 | Disposition | 366,158 | -- | -- | (100%) 366.16K to 0 | |
| 24-Jan-24 5:27 PM View: | Thomas Frank E See Remarks | Orchard Therapeutics Plc (ORTX) | 24-Jan-24 | Disposition | 92,081 | -- | -- | (100%) 92.08K to 0 | |
| 24-Jan-24 5:20 PM View: | Beck Joanne T. Director | Orchard Therapeutics Plc (ORTX) | 24-Jan-24 | Disposition | 9,294 | -- | -- | (100%) 9.29K to 0 | |
| 24-Jan-24 5:29 PM View: | Geraghty James A Director | Orchard Therapeutics Plc (ORTX) | 24-Jan-24 | Disposition | 44,391 | -- | -- | (100%) 44.39K to 0 | |
| 14-Mar-23 8:30 AM View: | Thomas Frank E See Remarks | Orchard Therapeutics Plc (ORTX) | 10-Mar-23 | Option Exercise | 20,000 | $0.46 | $9,182.00 | 28% 72.08K to 92.08K | |
| 13-Feb-23 8:09 AM View: | Thomas Frank E See Remarks | Orchard Therapeutics Plc (ORTX) | 09-Feb-23 | Option Exercise | 20,000 | $0.46 | $9,182.00 | 38% 52.08K to 72.08K | |
| 05-Apr-22 4:15 PM View: | Gaspar Bobby Chief Executive Officer Director | Orchard Therapeutics Plc (ORTX) | 01-Apr-22 | Private Purchase | 15,000 | $0.74 | $11,085.00 | 4% 353.16K to 368.16K | |
| 04-Apr-22 4:15 PM View: | Thomas Frank E See Remarks | Orchard Therapeutics Plc (ORTX) | 01-Apr-22 | Private Purchase | 10,000 | $0.75 | $7,474.00 | 24% 42.08K to 52.08K | |
| 23-Feb-21 9:51 AM View: | Fmr Corp 10% Owner | Orchard Therapeutics Plc (ORTX) | 19-Feb-21 | Conversion | 819,704 | -- | -- | (9%) 9.02M to 8.2M | |
| 10-Feb-21 1:39 PM View: | Fmr Corp 10% Owner | Orchard Therapeutics Plc (ORTX) | 05-Feb-21 | Market Sale | 2,045,510 | $6.98 | $14,277,700.00 | (17%) 12.24M to 10.2M | (19%) |
| 01-Feb-21 4:15 PM View: | Thomas Frank E See Remarks | Orchard Therapeutics Plc (ORTX) | 29-Jan-21 | Option Exercise | 10,000 | $2.44 | $24,400.00 | 31% 32.08K to 42.08K | |
| 12-Jan-21 4:48 PM View: | Gaspar Bobby Chief Executive Officer Director | Orchard Therapeutics Plc (ORTX) | 11-Jan-21 | Payment of Exercise | 3,411 | $6.72 | $22,921.90 | (< 1%) 356.57K to 353.16K | |
| 12-Jan-21 4:49 PM View: | Thomas Frank E See Remarks | Orchard Therapeutics Plc (ORTX) | 11-Jan-21 | Payment of Exercise | 3,706 | $6.72 | $24,904.30 | (10%) 35.79K to 32.08K | |
| 12-Jan-21 4:48 PM View: | Gaspar Bobby Chief Executive Officer Director | Orchard Therapeutics Plc (ORTX) | 08-Jan-21 | Grant | 6,250 | -- | -- | 2% 350.32K to 356.57K | |
| 12-Jan-21 4:49 PM View: | Thomas Frank E See Remarks | Orchard Therapeutics Plc (ORTX) | 08-Jan-21 | Grant | 10,667 | -- | -- | 42% 25.12K to 35.79K | |
| 06-Nov-20 4:32 PM View: | Ra Capital Management, LLC 10% Owner | Orchard Therapeutics Plc (ORTX) | 24-Sep-20 | Purchase | 473,327 | $4.61 | $2,182,040.00 | 5% 9.41M to 9.88M | |
| 06-Nov-20 4:32 PM View: | Ra Capital Management, LLC 10% Owner | Orchard Therapeutics Plc (ORTX) | 21-Aug-20 | Purchase | 64,642 | $4.62 | $298,610.00 | < 1% 9.34M to 9.41M | |
| 06-Nov-20 4:32 PM View: | Ra Capital Management, LLC 10% Owner | Orchard Therapeutics Plc (ORTX) | 20-Aug-20 | Purchase | 62,631 | $4.61 | $288,729.00 | < 1% 9.28M to 9.34M | |
| 06-Nov-20 4:32 PM View: | Ra Capital Management, LLC 10% Owner | Orchard Therapeutics Plc (ORTX) | 19-Aug-20 | Purchase | 64,254 | $4.68 | $300,989.00 | < 1% 9.22M to 9.28M | |
| 06-Nov-20 4:32 PM View: | Ra Capital Management, LLC 10% Owner | Orchard Therapeutics Plc (ORTX) | 18-Aug-20 | Purchase | 45,249 | $4.72 | $213,575.00 | < 1% 9.17M to 9.22M | |
| 06-Nov-20 4:32 PM View: | Ra Capital Management, LLC 10% Owner | Orchard Therapeutics Plc (ORTX) | 17-Aug-20 | Purchase | 8,235 | $4.74 | $39,033.90 | < 1% 9.16M to 9.17M | |
| 06-Nov-20 4:32 PM View: | Ra Capital Management, LLC 10% Owner | Orchard Therapeutics Plc (ORTX) | 14-Aug-20 | Purchase | 13,031 | $4.74 | $61,766.90 | < 1% 9.15M to 9.16M | |
| 06-Nov-20 4:32 PM View: | Ra Capital Management, LLC 10% Owner | Orchard Therapeutics Plc (ORTX) | 12-Aug-20 | Purchase | 16,291 | $4.74 | $77,219.30 | < 1% 9.13M to 9.15M | |
| 06-Nov-20 4:32 PM View: | Ra Capital Management, LLC 10% Owner | Orchard Therapeutics Plc (ORTX) | 10-Aug-20 | Purchase | 21,357 | $4.74 | $101,174.00 | < 1% 9.11M to 9.13M | |
| 15-Jun-20 5:03 PM View: | Thomas Frank E See Remarks | Orchard Therapeutics Plc (ORTX) | 11-Jun-20 | Option Exercise | 10,000 | $2.44 | $24,400.00 | 66% 15.12K to 25.12K | |
| 04-Mar-20 5:06 PM View: | Gaspar Bobby See Remarks Director | Orchard Therapeutics Plc (ORTX) | 02-Mar-20 | Option Exercise | 4,921 | $0.00 | $0.49 | 1% 350.32K to 355.24K | |
| 04-Mar-20 5:06 PM View: | Gaspar Bobby See Remarks Director | Orchard Therapeutics Plc (ORTX) | 02-Mar-20 | Planned Option Sale | 4,921 | $13.00 | $63,973.00 | (1%) 355.24K to 350.32K | |
| 06-Jan-20 5:34 PM View: | Fmr Corp 10% Owner | Orchard Therapeutics Plc (ORTX) | 02-Jan-20 | Sale | 8,753 | $13.41 | $117,378.00 | < 1% 12.26M to 12.26M | |
| 06-Jan-20 5:34 PM View: | Fmr Corp 10% Owner | Orchard Therapeutics Plc (ORTX) | 02-Jan-20 | Sale | 19,721 | $13.49 | $265,994.00 | (< 1%) 12.26M to 12.24M |
